The Gemini Study was a 14-week, open-label, non-comparative, office-based, multicenter trial to evaluate single-pill therapy in the treatment of concomitant hypertension and dyslipidemia. In addition ...
Non-communicable diseases, particularly cardiovascular diseases (CVDs), are currently the primary causes of mortality and morbidity worldwide. The Global Burden of Disease study revealed that 523 ...
Dyslipidemia is when the lipids in your blood are too high or too low. Estimates suggest that 53 percent of adults in the U.S. have lipid abnormalities. Lipids are a type of fat that make up the ...
MADRID, Spain—The European Society of Cardiology and the European Atherosclerosis Society (ESC/EAS) have updated their guidelines for the management of dyslipidemia, and while treatment goals have ...
Dyslipidemia is when the lipids in your blood are too high or too low. Estimates suggest that 53 percent of adults in the U.S. have lipid abnormalities. Lipids are a type of fat that make up the ...
Half of patients aged 40 years or older in Canada have dyslipidemia, and prevalence among patients aged 65 years or older, men, and those with obesity or other chronic conditions is even higher, ...
As the population ages, there is an urgent need to focus on how to deal with cognitive dysfunction. Cognitive dysfunction is a significant medical challenge, especially in developed countries, and is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results